Table 5.
HIV + participants without past COVID-19 infection (n = 211) | HIV+ participants with past COVID-19 infection (n = 45) | |||||||||||
Comparison | Wuhan | P | Delta | P | Omicron | P | Wuhan | P | Delta | P | Omicron | P |
Age >55 years | −10.5 (−23.3, 2.3) | 0.108 | −4.2 (−12.2, 3.8) | 0.301 | −1.1 (−2.2, 0.1) | 0.074 | −37.5 (−121.7, 46.7) | 0.374 | −52.4 (−130.0, 25.1) | 0.180 | 3.3 (−15.8, 22.5), | 0.728 |
Immune nonresponder (CD4+ <350 cells/μl, CD4+/CD8+ <0.75, suppressed VL) | 4.2 (−34.8, 43.1) | 0.832 | 2.1 (−13.7, 17.9) | 0.795 | 1.0 (−3.6, 5.7) | 0.669 | – | – | – | – | ||
Multimorbidity (≥2 comorbidities) | −10.2 (−22.7, 2.3) | 0.109 | −1.3 (−9.1, 6.6) | 0.754 | −1.3 (−2.5, 0.0) | 0.047 | 59.2 (−61.1, 179.5) | 0.326 | 29.4 (−59.9, 118.6) | 0.510 | 7.2 (−11.2, 25.6) | 0.431 |
HIV+ stable/reference (CD4+ ≥350 cells, suppressed VL and ≤1 comorbidity) | 3.0 (−11.4, 17.4) | 0.683 | 0.0 (−5.9, 6.0) | 0.997 | 0.9 (−0.4, 2.1) | 0.167 | −66.0 (−146.7, 14.6) | 0.106 | −33.9 (−114.5, 46.8) | 0.401 | −7.5 (−24.5, 9.4) | 0.372 |
VL, viral load.